SFN and non-small cell lung carcinoma: SFN was reported to inhibit EMT and metastasis in the NSCLC, the cell lines H1299, 95C, and 95D, by decreasing the expression of miR-616-5p. This miR directly targets GSK3β and decreases its expression resulting in the accumulation of β-catenin in the cytoplasm, which in turn activates Wnt signaling pathway, thus promoting CSCs survival.